 Connection
Joshua Solomon to Risk Factors
This is a "connection" page, showing publications Joshua Solomon has written about Risk Factors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.252 |
|
|
|
-
Koduri G, Solomon JJ. Identification, Monitoring, and Management of Rheumatoid Arthritis-Associated Interstitial Lung Disease. Arthritis Rheumatol. 2023 12; 75(12):2067-2077.
Score: 0.073
-
Solomon JJ, Danoff SK, Goldberg HJ, Woodhead F, Kolb M, Chambers DC, DiFranco D, Spino C, Haynes-Harp S, Hurwitz S, Peters EB, Dellaripa PF, Rosas IO. The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease. Adv Ther. 2019 11; 36(11):3279-3287.
Score: 0.055
-
Solomon JJ, Olson AL, Fischer A, Bull T, Brown KK, Raghu G. Scleroderma lung disease. Eur Respir Rev. 2013 Mar 01; 22(127):6-19.
Score: 0.035
-
Peljto AL, Furusawa H, Puthenvedu D, Lee JS, Steele MP, Brancato J, Cardwell J, Blumhagen RZ, de Andrade J, Bendstrup E, Blackwell TS, Bonella F, Borie R, Braybrooke R, Brown KK, Carbone RG, Christie JD, Costabel U, Crestani B, Davidsen JR, Dieude P, Donnelly SC, Egan J, Eickelberg O, Fernández Pérez ER, Fiddler CA, Foster EE, Gibson KF, Gudmundsson G, Guthridge JM, Henry MT, Hirani N, Jenkins RG, Kass DJ, Keane MP, Kokturk N, Kropski JA, Lederer D, Leone PM, Linderholm AL, Maher TM, Mathai SK, McCarthy C, McElroy AN, Mogulkoc N, Molina-Molina M, Molyneaux PL, Montesi SB, Nathan SD, Noth I, Olaniyi JA, Oldham JM, O'Reilly KMA, Palmisciano AJ, Pardo A, Parfrey H, Planas-Cerezales L, Poletti V, Porteous MK, Puppo F, Richeldi L, Rojas M, Salinas M, Schluger N, Selman M, Shea BS, Sterclova M, Solomon JJ, Tomassetti S, Vasakova MK, Zhang Y, Corte TJ, Dickinson JL, Glaspole I, Moodley YP, Prele CMA, Ryerson CJ, Wolters PJ, Jinno M, Miyata Y, Akagawa S, Narumoto O, Kita T, Shibayama T, Li T, Owan I, Wakamatsu K, Arai T, Hirose M, Kim DS, Ohta K, Ohta S, Park JS, Park MS, Yang IV, Fingerlin TE, Miyazaki Y, Okamoto T, Inoue Y, Song JW, Schwartz DA. Idiopathic pulmonary fibrosis risk loci in East Asian populations mirror those of European populations. Am J Respir Crit Care Med. 2026 07 01; 212(7):1522-1532.
Score: 0.022
-
Leavy OC, Kawano-Dourado L, Stewart ID, Quint JK, Solomon JJ, Borie R, Crestani B, Wain LV, Jenkins G, Dieudé P, Minelli C. Rheumatoid arthritis and idiopathic pulmonary fibrosis: a bidirectional Mendelian randomisation study. Thorax. 2024 05 20; 79(6):538-544.
Score: 0.019
-
Singh N, Varghese J, England BR, Solomon JJ, Michaud K, Mikuls TR, Healy HS, Kimpston EM, Schweizer ML. Impact of the pattern of interstitial lung disease on mortality in rheumatoid arthritis: A systematic literature review and meta-analysis. Semin Arthritis Rheum. 2019 12; 49(3):358-365.
Score: 0.013
-
Mannina A, Chung JH, Swigris JJ, Solomon JJ, Huie TJ, Yunt ZX, Truong TQ, Brown KK, Achcar RD, Olson AL, Cox CW, Kligerman SJ, Curran-Everett D, Fernández Pérez ER. Clinical Predictors of a Diagnosis of Common Variable Immunodeficiency-related Granulomatous-Lymphocytic Interstitial Lung Disease. Ann Am Thorac Soc. 2016 07; 13(7):1042-9.
Score: 0.011
-
Fernández Pérez ER, Swigris JJ, Forssén AV, Tourin O, Solomon JJ, Huie TJ, Olson AL, Brown KK. Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis. Chest. 2013 Nov; 144(5):1644-1651.
Score: 0.009
-
Swigris JJ, Olson AL, Huie TJ, Fernandez-Perez ER, Solomon JJ, Sprunger D, Brown KK. Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007. Chest. 2011 Nov; 140(5):1261-1266.
Score: 0.008
-
Swigris JJ, Olson AL, Huie TJ, Fernandez-Perez ER, Solomon J, Sprunger D, Brown KK. Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med. 2011 Jun 01; 183(11):1524-30.
Score: 0.008
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|